Evogene announces annual shareholder meeting
Reuters2026/07/31 20:02Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Evogene will hold its annual general meeting on Sept. 4, 2026 in Rehovot, Israel.
- Shareholders will vote on competing board slates: a seven-member slate backed by the board or a four-member slate nominated by Pure Capital shareholders.
- An amendment is proposed to lift authorized share capital by NIS 24 million to NIS 30 million, representing 150,000,000 ordinary shares.
- A reverse share split framework is up for approval, allowing a ratio between 1-for-2 and 1-for-15 at the board’s discretion within 18 months.
- Kost Forer Gabbay & Kasierer, an Ernst & Young member firm, is proposed for reappointment as independent auditor for 2026.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evogene Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-003741), on July 31, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Chainlink crypto brings US GDP data to 10 blockchains—Who is using it?
AMBCrypto•2026/09/02 23:33
ZincX says C$1.82 million private placement is fully subscribed
Reuters•2026/09/02 23:28
B3 says CADE clears purchase of 60% stake in CRDC, closing due by Oct. 31, 2026
Reuters•2026/09/02 23:27
Recursion Pharma director Blake Borgeson disposes of 30,000 shares valued at $100,200
Reuters•2026/09/02 23:27
Crypto prices
MoreBitcoin
BTC
$77,208.09
-0.17%
Ethereum
ETH
$2,385.86
-1.26%
Tether USDt
USDT
$0.9996
+0.01%
BNB
BNB
$686.65
+0.87%
XRP
XRP
$1.35
-0.04%
USDC
USDC
$0.9999
+0.01%
Solana
SOL
$99.93
+0.06%
TRON
TRX
$0.3250
+0.80%
Hyperliquid
HYPE
$81.5
-1.48%
Zcash
ZEC
$813.56
-1.69%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now